{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:01:29Z","timestamp":1792422089262,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Paragangliomas are rare neuroendocrine tumours arising from neural crest\u2013derived paraganglionic cells and form part of the pheochromocytoma\u2013paraganglioma (PPGL) spectrum. The World Health Organization (WHO) 5th edition classification emphasizes autonomic origin, distinguishing sympathetic from parasympathetic paragangliomas, and recognizes that all paragangliomas possess metastatic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the clinicopathological features of paragangliomas diagnosed over a 5-year period at a single tertiary care centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty histologically confirmed cases of paraganglioma resected between 2018 and 2023 were retrospectively reviewed. Hematoxylin and eosin (H&amp;E) and immunohistochemistry (IHC) slides were re-evaluated, and relevant clinical and radiological data were extracted from hospital records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort showed a female predominance (male-to-female ratio 1:1.8) with a median age of 49 years. The most common tumour site was the jugulotympanic region (30%), followed by intradural extramedullary (IDEM) locations (15%) and the retroperitoneum (15%). Two patients (10%) had metastatic disease involving the spine. Radiological findings were concordant with histology in 50% of cases. IHC was performed in 75% of cases and aided differentiation from histologic mimics. The Ki-67 proliferation index ranged from 1 to 2% in most cases, with one exception (4%). Follow-up data were available for 13 patients; one case showed local recurrence, and no syndromic associations were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Histological features alone are insufficient to predict tumour behaviour. Metastasis remains the only definitive criterion for malignancy, particularly when identified at sites lacking normal chromaffin tissue. Comprehensive clinicopathological assessment, incorporating radiology and immunohistochemistry, is essential for accurate diagnosis and management, and integration of molecular markers may further refine risk stratification in future studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-026-01771-1","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:53:54Z","timestamp":1770972834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cClinicopathological profile of paragangliomas: A 5-Year retrospective analysis from a single tertiary Centre\u201d"],"prefix":"10.1186","volume":"21","author":[{"given":"Geetha","family":"V","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8899-6604","authenticated-orcid":false,"given":"Megha","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Nayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Monappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailesh","family":"Pujary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"1771_CR1","volume-title":"WHO classification of tumours of endocrine and neuroendocrine tumours","year":"2022","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J, editors. WHO classification of tumours of endocrine and neuroendocrine tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2022.","edition":"5"},{"issue":"6","key":"1771_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/lio2.122","volume":"2","author":"JD Smith","year":"2017","unstructured":"Smith JD, Harvey RN, Darr OA, Prince ME, Bradford CR, Wolf GT, Else T, Basura GJ. Head and neck paragangliomas: a two-decade institutional experience and algorithm for management. Laryngoscope Investig Otolaryngol. 2017;2(6):380\u20139.","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"24","key":"1771_CR3","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3748\/wjg.15.3003","volume":"15","author":"N Feng","year":"2009","unstructured":"Feng N, Zhang WY, Wu XT. Clinicopathological analysis of paraganglioma with literature review. World J Gastroenterol. 2009;15(24):3003\u20138.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1771_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/0974-8237.135211","volume":"5","author":"T Mishra","year":"2014","unstructured":"Mishra T, Goel NA, Goel AH. Primary paraganglioma of the spine: a clinicopathological study of eight cases. J Craniovertebr Junction Spine. 2014;5(1):20\u20134.","journal-title":"J Craniovertebr Junction Spine"},{"issue":"3","key":"1771_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab. 2011;96(3):717\u201325.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1771_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona J, Ta\u00efeb D, Pacak K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev. 2017;38(6):489\u2013515.","journal-title":"Endocr Rev"},{"issue":"5","key":"1771_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K. Genotype\u2013phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr Relat Cancer. 2019;26(5):539\u201350.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1771_CR8","doi-asserted-by":"publisher","first-page":"T123","DOI":"10.1530\/ERC-13-0490","volume":"21","author":"RV Lloyd","year":"2014","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J. Pathology of pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2014;21(3):T123\u201336. https:\/\/doi.org\/10.1530\/ERC-13-0490.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"1771_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12022-015-9376-9","volume":"26","author":"CZ Liu","year":"2015","unstructured":"Liu CZ, Zhang Y, Wang EH. Thyroid paraganglioma: report of three cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma. Endocr Pathol. 2015;26(2):152\u20137. https:\/\/doi.org\/10.1007\/s12022-015-9376-9.","journal-title":"Endocr Pathol"},{"issue":"5","key":"1771_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1159\/000325596","volume":"52","author":"K Varma","year":"2008","unstructured":"Varma K, Jain S, Mandal S. Cytomorphologic spectrum in paraganglioma: a series of 15 cases. Acta Cytol. 2008;52(5):549\u201356. https:\/\/doi.org\/10.1159\/000325596.","journal-title":"Acta Cytol"},{"issue":"9","key":"1771_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/jcm7090242","volume":"7","author":"N Kimura","year":"2018","unstructured":"Kimura N, Takekoshi K, Naruse M. Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine. J Clin Med. 2018;7(9):242.","journal-title":"J Clin Med"},{"issue":"4","key":"1771_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12022-024-09830-3","volume":"35","author":"CJ de Bresser","year":"2024","unstructured":"de Bresser CJ, de Krijger RR. The molecular classification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease. Endocr Pathol. 2024;35(4):279\u201392.","journal-title":"Endocr Pathol"},{"issue":"6","key":"1771_CR13","doi-asserted-by":"publisher","first-page":"101939","DOI":"10.1016\/j.beem.2024.101939","volume":"38","author":"E Boehm","year":"2024","unstructured":"Boehm E, Gill AJ, Clifton-Bligh R, Tothill RW. Recent progress in molecular classification of Phaeochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2024;38(6):101939.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1771_CR14","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1038\/ncomms7140","volume":"5","author":"L Fishbein","year":"2014","unstructured":"Fishbein L, Merrill PH, Duh QY, et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun. 2014;5:7140. https:\/\/doi.org\/10.1038\/ncomms7140.","journal-title":"Nat Commun"},{"issue":"21","key":"1771_CR15","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-18-0658","volume":"24","author":"A Lopez-Jimenez","year":"2018","unstructured":"Lopez-Jimenez A, Letouz\u00e9 E, Burnichon N, et al. Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma. Clin Cancer Res. 2018;24(21):5268\u201379. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0658.","journal-title":"Clin Cancer Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-026-01771-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-026-01771-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:13:30Z","timestamp":1781633610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-026-01771-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1771"],"URL":"https:\/\/doi.org\/10.1186\/s13000-026-01771-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with institutional ethical standards. Ethics committee approval was obtained from the Institutional Ethics Committee. (Institutional Ethical committee reference number: IEC: 344\/2023, Dated 13th September 2023) As this was a retrospective analysis of archived material and medical records, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}